# AQAL Integral Investing

> AQAL Integral Investing is a VC fund backing Health Care and Medical Device. See 12 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Munich, Germany
- Total investments: 12
- Last investment: Jun 2023
- Lead investor: 8%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/aqalgroup
- X (Twitter): https://twitter.com/AQAL_Group
- Website: https://aqalcapital.com
- Facebook: https://www.facebook.com/AQALMunich

AQAL Integral Investing is a VC fund in Munich focused on Health Care and Medical Device. AQAL Capital invests in state-of-the-art exponential technology companies which have the potential for integral impact, including substantial growth, while implementing the UN SDGs within the Planetary Boundaries.We focus on seed and early-stage companies. Their leadership team must be strong, their technology must be proven, and should have ashort runway to cash flow break-even.Our regional focus is the European Union with the main emphasis on DACH (Germany, Austria, Switzerland). A few selected investments are also made in the San Francisco Bay Area.According to our Integral Investing philosophy, the business models of our investees must be transferable to other countries, be scalable to market leadership, and deliver sustainable and risk-adjusted returns on multiple bottom lines as defined by our 6Ps: Parity of People, Planet, and Profit — with Passion and Purpose.Given our investing expertise, background, and entrepreneurial experience, we are focusing on three main sectors of innovation for life in the 21st century:Exponential Technology & Digital Evolution: Internet Infrastructure, Artificial Intelligence, B2B IT Solutions, Digital Design Green Technology: Renewable Energy, Energy Efficiency, CleanTech, Circular Economy Life in the 21st century: Future Mobility, Nutrition & Agro, Med Tech, Media & Entertainment Tech

## Contacts

5 contacts available for AQAL Integral Investing. Shizune tracks 2 team members at AQAL Integral Investing. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/aqal-integral-investing?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.5M–$1.5M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 33% |
| Medical Device | 3 | 25% |
| Medical | 2 | 17% |
| Biotechnology | 2 | 17% |
| Information Technology | 2 | 17% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 8 | 67% |
| Angel | 1 | 8% |
| Pre-Seed | 1 | 8% |
| Venture - Series Unknown | 1 | 8% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 6 | 50% |
| United States | 2 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Mariana Bozesan | Founder & Partner | 1 | https://shizune.co/investors/profile/mariana-bozesan |
| Tom Schulz | Co-founder & Managing Partner | 2 | https://shizune.co/investors/profile/tom-schulz-2 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| DNTOX | We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments! | $1.5M | Seed | Jun 14, 2023 |  |
| wondder | Wondder is a virtual reality and ethical artificial intelligence training company. | $538.1K | Angel | Jun 12, 2023 |  |
| wondder | Wondder is a virtual reality and ethical artificial intelligence training company. |  | Seed | Mar 06, 2023 |  |
| DNTOX | We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments! |  | Seed | Feb 14, 2023 |  |
| wondder | Wondder is a virtual reality and ethical artificial intelligence training company. |  | Pre-Seed | Jan 01, 2023 |  |
| Elona Health | Elona Health develops digital health application to support treatment for patients and therapists alike. |  | Seed | Nov 01, 2022 |  |
| cureVision | cureVision is an AI-based medical imaging and diagnostic solutions for vascular surgeons and care staff, specialist for chronic wounds. | $1.5M | Seed | Oct 22, 2022 |  |
| Tembo Health | Tembo Health is a telemedicine company serving retirement homes, senior care centers and skilled nursing facilities to connect patients with specialty services like psychiatry and cardiology. The platform connects the specialists to patient data and collaborates with the nursing staff to provide better care plans. |  | Seed | Sep 15, 2022 |  |
| Tembo Health | Tembo Health is a telemedicine company serving retirement homes, senior care centers and skilled nursing facilities to connect patients with specialty services like psychiatry and cardiology. The platform connects the specialists to patient data and collaborates with the nursing staff to provide better care plans. |  | Venture - Series Unknown | Aug 15, 2022 |  |
| PhysioCue | PhysioCue is a medical device company that has developed anti-hypertensive and migraine/headache medical devices which have been clinically proven to immediately reduce the high blood pressure of hypertensive patients and shown to relieve migraine/headache pain. These devices are non-invasive and work by controlled cold therapy to triggerthe carotid artery baroreceptor reflex. Unlike drug treatments and invasive procedures, their PhysioCue therapy is efficient, safe, easy to use, and has none of the side effects associated with anti-hypertensive drugs. PhysioCue is also developing a wearable mobile health device. |  | Seed | Mar 18, 2019 |  |

10 of 12 investments shown.

## Co-investors
- [Allygatr](https://shizune.co/investors/profile/allygatr) — VC Fund, 2 deals together
- [Bool Capital](https://shizune.co/investors/profile/bool-capital) — VC Fund, 1 deal together
- [Companisto](https://shizune.co/investors/profile/companisto) — VC Fund, 1 deal together
- [Evodia](https://shizune.co/investors/profile/evodia) — VC Fund, 1 deal together
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Reach Capital](https://shizune.co/investors/profile/reach-capital) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [GSV Ventures](https://shizune.co/investors/profile/gsv-acceleration) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Education Investors in Germany](https://shizune.co/investors/education-investors-germany)
- [EdTech Investors in Germany](https://shizune.co/investors/edtech-investors-germany)
- [Education VC Funds in Germany](https://shizune.co/investors/education-vc-funds-germany)
- [EdTech VC Funds in Germany](https://shizune.co/investors/edtech-vc-funds-germany)
- [Medical Device Investors in Germany](https://shizune.co/investors/medical-device-investors-germany)
- [Medical Device VC Funds in Germany](https://shizune.co/investors/medical-device-vc-funds-germany)

## FAQ

### What does AQAL Integral Investing invest in?

AQAL Integral Investing invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Angel stage. Most of the 12 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is AQAL Integral Investing's check size?

AQAL Integral Investing typically joins rounds of $1.5M–$1.5M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds AQAL Integral Investing participates in.

### How do I contact AQAL Integral Investing?

Public channels for AQAL Integral Investing include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at AQAL Integral Investing?

The team at AQAL Integral Investing includes Mariana Bozesan (Founder & Partner) and Tom Schulz (Co-founder & Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co